FLT3 inhibitors trigger ferroptosis, exposing new weakness in acute myeloid leukemia. A study published in Nature Cell Biology reports a new vulnerability in acute myeloid leukemia (AML) that might lead to novel therapies to treat the cancer while minimizing harm to normal cells.
A apuração publicada por medicalxpress.com vira base para uma leitura editorial direta e contextualizada.
Trechos de apoio da pauta: A study published in Nature Cell Biology reports a new vulnerability in acute myeloid leukemia (AML) that might lead to novel therapies to treat the cancer while minimizing harm to normal cells. Researchers at Baylor College of Medicine and collaborating institutions studied a new mechanism by which drugs that neutralize FLT3 mutations work.
- Ponto de atenção: flt3.
- Ponto de atenção: inhibitors.
- Ponto de atenção: trigger.
Em resumo, a leitura editorial acompanha o impacto do tema no nicho Saúde.
